Tata India Pharma & Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹166 Cr | ₹949 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open-ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.34 | 2.21 |
| Manager | Rohan Korde | Meeta Shetty |
| ISIN Code | INF00XX01BL5 | INF277K016A9 |
| Exits Load | Exit load of 1% if redeemed within 12 months./365 | Exit load of 0.25% if redeemed within 30 days./365 |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -1.76% | -3.88% |
| 6 Month | 25.35% | 21.49% |
| 1 Year | 48.94% | 44.8% |
| 3 Year | 18.65% | 20.2% |
| 5 Year | - | 27.32% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 40.97% | 34.35% |
| 3 Year | - | 31.62% |
| 5 Year | - | 25.67% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 20.74% | 6.67% |
| 3 Year | 19.19% | 17.46% |
| 5 Year | - | 14.22% |
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.52% | 14.23% |
| Sharp | - | 0.74% |
| Beta | - | 0.9% |
| Alpha | - | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Rohan Korde | Meeta Shetty |
| Total AUM | ₹4626 Cr | ₹17847 Cr |
| Fund Manage | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 0.48 | 5.34 |
| Mid Cap | 28.05 | 39.68 |
| Small Cap | 32.19 | 16.33 |
| Large Cap | 39.28 | 38.65 |
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 0.48 | 3.05 |
| Healthcare | 96.77 | 93.35 |
| Chemicals | 2.75 | 1.31 |
| Services | - | 2.29 |
Top Comparisons
Mahindra Manulife ELSS Tax Saver Fund- Regular Plan - Growth
3Y Returns12.46%
Parag Parikh Tax Saver Fund Regular - Growth
3Y Returns17.64%
ITI Arbitrage Fund Regular - Growth
3Y Returns5.16%
SBI Arbitrage Opportunities Fund - Regular Plan - Gr
3Y Returns6.37%
BANDHAN Low Duration Fund - Regular Plan - Growth
3Y Returns5.93%
Canara Robeco Savings Fund - Regular Plan - Growth Option
3Y Returns5.97%
UTI Credit Risk Fund - Regular Plan - Growth Option
3Y Returns5.96%
Baroda BNP Paribas Credit Risk Fund -Regular-Growth Option
3Y Returns6.52%